Skip to main content
Erschienen in: Brain Structure and Function 7/2018

07.06.2018 | Original Article

Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks

verfasst von: Francesca M. Filbey, Suril Gohel, Shikha Prashad, Bharat B. Biswal

Erschienen in: Brain Structure and Function | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Concomitant cannabis and nicotine use is more prevalent than cannabis use alone; however, to date, most of the literature has focused on associations of isolated cannabis and nicotine use limiting the generalizability of existing research. To determine differential associations of concomitant use of cannabis and nicotine, isolated cannabis use and isolated nicotine use on brain network connectivity, we examined systems-level neural functioning via independent components analysis (ICA) on resting state networks (RSNs) in cannabis users (CAN, n = 53), nicotine users (NIC, n = 28), concomitant nicotine and cannabis users (NIC + CAN, n = 26), and non-users (CTRL, n = 30). Our results indicated that the CTRL group and NIC + CAN users had the greatest functional connectivity relative to CAN users and NIC users in 12 RSNs: anterior default mode network (DMN), posterior DMN, left frontal parietal network, lingual gyrus, salience network, right frontal parietal network, higher visual network, insular cortex, cuneus/precuneus, posterior cingulate gyrus/middle temporal gyrus, dorsal attention network, and basal ganglia network. Post hoc tests showed no significant differences between (1) CTRL and NIC + CAN and (2) NIC and CAN users. These findings of differential associations of isolated vs. combined nicotine and cannabis use demonstrate an interaction between cannabis and nicotine use on RSNs. These unique and combined mechanisms through which cannabis and nicotine influence cortical network functional connectivity are important to consider when evaluating the neurobiological pathways associated with cannabis and nicotine use.
Literatur
Zurück zum Zitat Amos A, Wiltshire S, Bostock Y et al (2004) ‘You can’t go without a fag… you need it for your hash’—a qualitative exploration of smoking, cannabis and young people. Addiction 99:77–81CrossRefPubMed Amos A, Wiltshire S, Bostock Y et al (2004) ‘You can’t go without a fag… you need it for your hash’—a qualitative exploration of smoking, cannabis and young people. Addiction 99:77–81CrossRefPubMed
Zurück zum Zitat Biswal BB, Kylen JV, Hyde JS (1997) Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR Biomed 10:165–170CrossRefPubMed Biswal BB, Kylen JV, Hyde JS (1997) Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR Biomed 10:165–170CrossRefPubMed
Zurück zum Zitat Bonn-Miller MO, Zvolensky MJ, Johnson KA (2010) Uni-morbid and co-occurring marijuana and tobacco wue: examination of concurrent associations with negative mood states. J Addict Dis 29:68–77CrossRefPubMedPubMedCentral Bonn-Miller MO, Zvolensky MJ, Johnson KA (2010) Uni-morbid and co-occurring marijuana and tobacco wue: examination of concurrent associations with negative mood states. J Addict Dis 29:68–77CrossRefPubMedPubMedCentral
Zurück zum Zitat Claus ED, Blaine SK, Filbey FM et al (2013) Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38:2363–2372CrossRefPubMedPubMedCentral Claus ED, Blaine SK, Filbey FM et al (2013) Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38:2363–2372CrossRefPubMedPubMedCentral
Zurück zum Zitat Cohen C, Perrault G, Voltz C et al (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463CrossRefPubMed Cohen C, Perrault G, Voltz C et al (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463CrossRefPubMed
Zurück zum Zitat Fagerstrom K-O, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182CrossRefPubMed Fagerstrom K-O, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182CrossRefPubMed
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New York First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New York
Zurück zum Zitat Gfroerer JC, Greenblatt JC, Wright DA (1997) Substance use in the US college-age population: differences according to educational status and living arrangement. Am J Public Health 87:62–65CrossRefPubMedPubMedCentral Gfroerer JC, Greenblatt JC, Wright DA (1997) Substance use in the US college-age population: differences according to educational status and living arrangement. Am J Public Health 87:62–65CrossRefPubMedPubMedCentral
Zurück zum Zitat Panlilio LV, Solinas M, Matthews SA, Goldberg SR (2007) Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32:646–657CrossRefPubMed Panlilio LV, Solinas M, Matthews SA, Goldberg SR (2007) Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32:646–657CrossRefPubMed
Zurück zum Zitat Sobell LC, Sobell MB (1992) Timeline Follow-Back. In: Litten RZ, Allen JP (eds) Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press, Totowa, pp 41–72CrossRef Sobell LC, Sobell MB (1992) Timeline Follow-Back. In: Litten RZ, Allen JP (eds) Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press, Totowa, pp 41–72CrossRef
Zurück zum Zitat Substance Abuse and Mental Health Services Administration (2014) Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration, Rockville Substance Abuse and Mental Health Services Administration (2014) Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration, Rockville
Zurück zum Zitat Taylor PA, Gohel S, Di X et al (2012) Functional covariance networks: obtaining resting-state networks from intersubject variability. Brain Connect 2:203–217CrossRefPubMedPubMedCentral Taylor PA, Gohel S, Di X et al (2012) Functional covariance networks: obtaining resting-state networks from intersubject variability. Brain Connect 2:203–217CrossRefPubMedPubMedCentral
Zurück zum Zitat Valjent E, Mitchell JM, Besson M-J et al (2002) Behavioural and biochemical evidence for interactions between ∆9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564–578CrossRefPubMedPubMedCentral Valjent E, Mitchell JM, Besson M-J et al (2002) Behavioural and biochemical evidence for interactions between ∆9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564–578CrossRefPubMedPubMedCentral
Metadaten
Titel
Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks
verfasst von
Francesca M. Filbey
Suril Gohel
Shikha Prashad
Bharat B. Biswal
Publikationsdatum
07.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Brain Structure and Function / Ausgabe 7/2018
Print ISSN: 1863-2653
Elektronische ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-018-1690-5

Weitere Artikel der Ausgabe 7/2018

Brain Structure and Function 7/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.